CRYOPORT, INC. Inventory, Finished Goods, Net of Reserves
CRYOPORT, INC. (CYRX) had Inventory, Finished Goods, Net of Reserves of $6.18 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-06
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $6.18M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $6.31M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $6.72M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $7.47M.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $6.18M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $6.31M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $6.72M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $7.47M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $8.40M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $7.47M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $5.74M 10-K · filed 2026-03-05 | $6.18M 10-K · filed 2025-03-07 |
| 2024-09-30 | $8.29M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $7.62M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $9.47M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $9.50M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $10.46M 10-Q · filed 2023-11-09 | |
| 2022-12-31 | $8.50M 10-K · filed 2024-03-13 | |
| 2013-12-31 | $0.00 10-Q · filed 2014-02-13 | |
| 2013-09-30 | $8.62K 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $13.20K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $10.68K 10-Q · filed 2014-02-13 | |
| 2012-12-31 | $26.97K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $27.58K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $24.84K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $19.20K 10-Q · filed 2013-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |